Family CFO »

Endonovo Therapeutics shares owned by Family CFO

Quarter-by-quarter ownership of Endonovo Therapeutics (ENDV) shares owned by Family CFO from 13F filings

Historical chart of Family CFO investment in Endonovo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Endonovo Therapeutics held by Family CFO consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Endonovo Therapeutics by Family CFO

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 60 0.00
2023-12-31 $1 60 0.02
2023-09-30 $1 60 0.02
2023-06-30 $1 60 0.02
2023-03-31 $1 60 0.02
2022-12-31 $1 60 0.02
2022-09-30 $0 60 0.00
2022-06-30 $1 60 0.02
2022-03-31 $0 60 0.00
2021-12-31 $0 60 0.00

Top funds holding Endonovo Therapeutics